HEALTH4LIFE C.I.C.

Company Registration Number:
11154473 (England and Wales)

Unaudited statutory accounts for the year ended 31 January 2023

Period of accounts

Start date: 1 February 2022

End date: 31 January 2023

HEALTH4LIFE C.I.C.

Contents of the Financial Statements

for the Period Ended 31 January 2023

Profit and loss
Balance sheet
Additional notes
Balance sheet notes
Community Interest Report

HEALTH4LIFE C.I.C.

Profit And Loss Account

for the Period Ended 31 January 2023

2023 2022


£

£
Turnover: 4,468 3,744
Cost of sales: ( 4,605 ) ( 5,928 )
Gross profit(or loss): (137) (2,184)
Operating profit(or loss): (137) (2,184)
Profit(or loss) before tax: (137) (2,184)
Profit(or loss) for the financial year: (137) (2,184)

HEALTH4LIFE C.I.C.

Balance sheet

As at 31 January 2023

Notes 2023 2022


£

£
Called up share capital not paid: 0 0
Fixed assets
Tangible assets: 3 1 1
Total fixed assets: 1 1
Current assets
Stocks:   0 0
Debtors:   0 0
Cash at bank and in hand: 200 873
Investments:   0 0
Total current assets: 200 873
Net current assets (liabilities): 200 873
Total assets less current liabilities: 201 874
Creditors: amounts falling due after more than one year:   0 0
Provision for liabilities: 0 0
Accruals and deferred income: 0 0
Total net assets (liabilities): 201 874
Capital and reserves
Called up share capital: 1 1
Profit and loss account: 200 873
Total Shareholders' funds: 201 874

The notes form part of these financial statements

HEALTH4LIFE C.I.C.

Balance sheet statements

For the year ending 31 January 2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 11 October 2023
and signed on behalf of the board by:

Name: Alistair Robert Slater
Status: Director

The notes form part of these financial statements

HEALTH4LIFE C.I.C.

Notes to the Financial Statements

for the Period Ended 31 January 2023

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

HEALTH4LIFE C.I.C.

Notes to the Financial Statements

for the Period Ended 31 January 2023

  • 2. Employees

    2023 2022
    Average number of employees during the period 1 1

HEALTH4LIFE C.I.C.

Notes to the Financial Statements

for the Period Ended 31 January 2023

3. Tangible assets

Land & buildings Plant & machinery Fixtures & fittings Office equipment Motor vehicles Total
Cost £ £ £ £ £ £
At 1 February 2022 1 1
Additions
Disposals
Revaluations
Transfers
At 31 January 2023 1 1
Depreciation
At 1 February 2022
Charge for year
On disposals
Other adjustments
At 31 January 2023
Net book value
At 31 January 2023 1 1
At 31 January 2022 1 1

COMMUNITY INTEREST ANNUAL REPORT

HEALTH4LIFE C.I.C.

Company Number: 11154473 (England and Wales)

Year Ending: 31 January 2023

Company activities and impact

Having supplied and fitted several defibrillators (publicly accesssible) this past year health4life has continues to expand into health promoting walks and events

Consultation with stakeholders

All events and fundraising has been done where the public in the area have expressed an interest

Directors' remuneration

The total amount paid or receivable by directors in respect of qualifying services was £3705

Transfer of assets

No transfer of assets other than for full consideration

This report was approved by the board of directors on
11 October 2023

And signed on behalf of the board by:
Name: Alistair Robert Slater
Status: Director